David Fajgenbaum, MD, MBA, MSc co-founded Every Cure after he experienced firsthand how prescription drugs had the potential to be repurposed in treating and curing other diseases. At CGI 2022, he announced Every Cure’s commitment to developing an open-source database and launching the first clinical trial of the most promising drug repurposing opportunity within 18 months. ? This week, Every Cure announced that they have received a five-year, $60 million commitment through TED’s The Audacious Project to advance promising repurposed treatments for patients around the world. Congratulations from the CGI team on this important new funding — join us in celebrating their impact on the global stage!
Every Cure Receives Five-Year, $60 Million Commitment Through TED's Audacious Project to Repurpose Medications for Global Impact. Full Press Release: https://lnkd.in/eCcwt4Vn TED Conferences The Audacious Project